Sqz Biotechnologies Revenue vs. Total Debt
| SQZDelisted Stock | USD 0.10 0.04 28.57% |
For Sqz Biotechnologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sqz Biotechnologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sqz Biotechnologies Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sqz Biotechnologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sqz Biotechnologies Co over time as well as its relative position and ranking within its peers.
Sqz |
Sqz Biotechnologies Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sqz Biotechnologies's current stock value. Our valuation model uses many indicators to compare Sqz Biotechnologies value to that of its competitors to determine the firm's financial worth. Sqz Biotechnologies Co is rated second in revenue category among its peers. It is rated fifth in total debt category among its peers making up about 1.31 of Total Debt per Revenue. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sqz Biotechnologies' earnings, one of the primary drivers of an investment's value.Sqz Revenue vs. Competition
Sqz Biotechnologies Co is rated second in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 83.29 Million. Sqz Biotechnologies totals roughly 21.03 Million in revenue claiming about 25% of equities under Health Care industry.
Sqz Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sqz Biotechnologies |
| = | 21.03 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Sqz Biotechnologies |
| = | 27.47 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Sqz Total Debt vs Competition
Sqz Biotechnologies Co is rated fifth in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 287.18 Million. Sqz Biotechnologies holds roughly 27.47 Million in total debt claiming about 10% of equities under Health Care industry.
Sqz Biotechnologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sqz Biotechnologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sqz Biotechnologies will eventually generate negative long term returns. The profitability progress is the general direction of Sqz Biotechnologies' change in net profit over the period of time. It can combine multiple indicators of Sqz Biotechnologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. SQZ Biotechnologies Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts. Sqz Biotechnologies operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 113 people.
Sqz Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sqz Biotechnologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sqz Biotechnologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sqz Biotechnologies' important profitability drivers and their relationship over time.
Use Sqz Biotechnologies in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sqz Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sqz Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Sqz Biotechnologies Pair Trading
Sqz Biotechnologies Co Pair Trading Analysis
The ability to find closely correlated positions to Sqz Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sqz Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sqz Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sqz Biotechnologies Co to buy it.
The correlation of Sqz Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sqz Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sqz Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sqz Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sqz Biotechnologies position
In addition to having Sqz Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Artificial Intelligence Thematic Idea Now
Artificial Intelligence
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |